SPOTLIGHT ON Is this the future of SKINCARE?

A French biotech skincare brand makes big promises about getting skin results without irritation. Beauty director Sally Hunwick went to the global launch to find out if green biotech really is the next big thing

-  Sally Hunwick

In a world where we are spoilt for choice with beauty products, there can be a tendency to overdo it. Add to that technology that’s racing ahead with in-clinic treatments, and there is the very real issue of pushing our complexion beyond its limits. What does that mean? It means more of us than ever before are ending up with sensitised skin and a compromised barrier.

If you feel like you are hearing about your skin barrier a lot these days, you’re not wrong. Suddenly, doctors, aesthetic nurses and clinicians are seeing patient after patient coming in with inflamed, red and irritated skin (indicating a compromised skin barrier) that can no longer seem to tolerate anything being put on it at all.

Orveda, a new luxury line of biotech skincare by global beauty company Coty, promises to bring back calmer, more resilient skin while helping to slow the signs of ageing. marie claire attended the global launch of the brand in Cannes in the South of France recently, and the range is now available for shipping to Australia.

Starting as an idea 10 years ago, with four years on the drawing board and near-endless research into biotech and what makes our skin tick, this launch is a big moment for Coty. Co-founded by Coty CEO Sue Nabi and Orveda CEO Nicolas Vu, Orveda heralds a new moment in skincare. Why? Because it promises the holy grail: effective and efficient skincare that won’t irritate or inflame skin.